Gastric-derived peptide that promotes angiogenesis and accelerates tendon, ligament, and bone healing.
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids derived from a protein found in human gastric juice. Originally isolated from the protective proteins that line the stomach, BPC-157 has demonstrated remarkable tissue-healing properties across multiple organ systems in preclinical research. Its primary mechanism involves promoting angiogenesis — the formation of new blood vessels — which is essential for delivering oxygen and nutrients to damaged tissues during the repair process.
At the molecular level, BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts and promotes the production of key growth factors including VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor). This cascade of signaling leads to accelerated healing in tendons, ligaments, bones, and soft tissues. The peptide also modulates the nitric oxide (NO) system, which plays a critical role in blood vessel formation, inflammation regulation, and tissue protection.
Beyond its musculoskeletal benefits, BPC-157 has shown gastroprotective properties, supporting the integrity of the gastrointestinal lining and promoting healing of ulcers, inflammatory bowel conditions, and gut-barrier dysfunction. Its neuroprotective effects include support for dopaminergic and serotonergic pathways, contributing to its potential applications in recovery from nerve damage and neurotoxicity.
Supports cartilage regeneration and reduces inflammation in load-bearing joints, helping restore mobility and reduce pain.
Promotes integrity of the gastrointestinal mucosal barrier, supporting recovery from ulcers, leaky gut, and inflammatory bowel conditions.
Accelerates tendon-to-bone healing by upregulating growth factor expression and promoting collagen synthesis at the injury site.
Modulates inflammatory cytokine cascades, reducing excessive inflammation while maintaining the body's natural healing response.
Supports dopaminergic and serotonergic pathways, showing potential for nerve damage recovery and neurotoxicity protection.
Dealing with tendon strains, ligament tears, or joint injuries and seeking faster, more complete recovery to return to training.
Recovering from orthopedic surgery and looking to support tissue healing, reduce inflammation, and accelerate the rehabilitation timeline.
Experiencing GI issues such as leaky gut, IBS symptoms, or ulcers, and seeking a peptide that supports mucosal repair and gut-barrier integrity.
BPC-157 is included in several physician-designed protocol stacks:
BPC-157 has been the subject of extensive preclinical research, with hundreds of published studies demonstrating its tissue-protective and healing properties across musculoskeletal, gastrointestinal, and nervous system models. While human clinical trials are still emerging, the breadth of animal data is substantial and consistently shows accelerated healing of tendons, ligaments, muscles, and the GI tract. The peptide's safety profile in these studies has been favorable, with no reported toxic effects even at high doses. Research continues to expand, with ongoing investigations into its potential applications in inflammatory bowel disease, traumatic brain injury recovery, and adjunctive post-surgical care.
BPC-157 is a 15-amino-acid synthetic peptide derived from a protective protein found in human gastric juice known as Body Protection Compound. It is stable in gastric acid, which is unusual for peptides of this size.
BPC-157 is typically prescribed as a subcutaneous injection. Your physician will determine the appropriate dosing schedule and administration route based on your specific condition and treatment goals.
Many patients report noticeable improvements within 2–4 weeks, though timelines vary depending on the nature and severity of the condition being treated. Your physician will set realistic expectations during consultation.
Yes. BPC-157 is commonly prescribed alongside TB-500 in recovery stacks, and may also be combined with growth-hormone secretagogues like Ipamorelin and CJC-1295 for comprehensive healing protocols.
BPC-157 is not currently FDA-approved as a standalone drug. It is prescribed off-label by licensed physicians and compounded at 503a/503b pharmacies in accordance with applicable regulations.
Individual results may vary. This information is for educational purposes only. All peptide therapies require a physician evaluation and prescription.
A physician will evaluate whether BPC-157 is right for your recovery goals.
Check Your Eligibility →